ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Orchid Pharma Limited has scheduled a board meeting for August 14, 2026, to consider and approve its Q1 FY 2026-27 financial results and restated annual results.
Orchid Pharma has scheduled a board meeting for August 1, 2026, to approve share allotments related to the amalgamation with Dhanuka Laboratories Limited.
Orchid Pharma scheduled a board meeting for May 25, 2026, to approve fiscal 2026 audited financial results. The trading window remains closed until 48 hours post-declaration.